Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

Virology

Volumn 254, Issue 1, 1999, Pages 138-146

  Mozdzanowska, Krystyna ^a   Maiese, Krista ^a   Furchner, Michelle ^a   Gerhard, Walter ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TARGET CELL; VIRUS INFECTION;

EID: 0033079822     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9534     Document Type: Article

References (59)

1. Amor, S., Scallan, M. F., Morris, M. M., Dyson, H., and Fazakerley, J. K. (1996). Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77, 281-291.
2. Baldridge, J. R., and Buchmeier, M. J. (1992). Mechanism of antibody-mediated protection against lymphocytic choriomeningitis virus infection: Mother-to-baby transfer of humoral protection. J. Virol. 66, 4252-4257.
3. Black, R. A., Rota, P. A., Gorodkova, N., Klenk, H-D., and Kendal, A. P. (1993). Antibody response to the M2 protein of influenza A virus expressed in insect cells. J. Virol. 74, 143-146.
4. Boere, W. A. M., Benaissa-Trouw, B. J., Harmsen, T., Erich, T., Kraaijeveld, C. A., and Snippe, H. (1985). Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J. Virol. 54, 546-551.
5. Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A., and Greenberg, H. B. (1996). Protective effect of rotavirus VP6-specific IgA monclonal antibodies that lack neutralizing activity. Science 272, 104-107.
6. Couch, R. B., Kasel, J. A., Geri, J. L., Schulman, J. L., and Kilbourne, E. D. (1974). Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J. Infect. Dis. 129, 411-420.
7. Denkers, E. Y., Badger, C. C., Ledbetter, J. A., and Bernstein, I. D. (1985). Influence of antibody isotype on passive serotherapy of lymphoma. J. Immunol. 135, 2183-2186.
8. Doherty, P. C., Allen, W., Eichelberger, M., and Carding, S. R. (1992). Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10, 123-151.
9. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159, 105-117.
10. Epstein, S. L., Misplon, J. A., Lawson, C. M., Subbarao, E. K., Connors, M., and Murphy, B. R. (1993). β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150, 5484-5493.
11. Falgout, B., Bray, M., Schlesinger, J. J., and Lai, C. J. (1990). Immunization of mice with recombinant vaccinia virus expressing authentic Dengue virus nonstructural protein NS1 protects against lethal Dengue virus encephalitis. J. Virol. 64, 4356-4363.
12. Gerhard, W., Mozdzanwoska, K., and Furchner, M. (1996). The nature of heterosubtypic immunity. In "Options for the Control of Influenza III" (L. E. Brown, A. W. Hampson, and R. G. Webster, Eds.), pp. 235-243. Elsevier, Amsterdam.
13. Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G., and Maise, K. (1997). Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159, 95-103.
14. Ghetie, V., Hubbard, J. G., Kim, J-K., Tsen, M-F., Lee, Y., and Ward, E. S. (1996). Abnormally short serum half-lives of IgG in β2-microglobulin-deficient mice. Eur. J. Immunol. 26, 690-696.
15. Griffin, D., Levine, B., Tyor, W., Ubol, S., and Despres, P. (1997). The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 159, 155-161.
16. Hazenbos, W. L. W., Heijnen, I. A. F. M., Meyer, D., Hofhuis, F. M. A., de Lavalette, C. R., Schmidt, R. E., Capel, P. J. A., van de Winkel, J. G. J., Gessner, J. E., van den Berg, T. K., and Verbeek, J. S. (1998). Murine IgG1 complexes trigger immune effector functions predominantly via FcγRIII (CD16). J. Immunol. 161, 3026-3032.
17. + T cells requires direct targeting to virus-infected epithelium. Eur. J. Immunol. 25, 111-116.
18. Hughey, P. G., Roberts, P. C., Holsinger, L. J., Zebedee, S. L., Lamb, R. A., and Compans, R. W. (1995). Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 212, 411-421.
19. Hunt, A. R., Short, W. A., Johnson, A. J., Bolin, R. A., and Roehrig, H. T. (1991). Synthetic peptides of the E2 glycoprotein of venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology 185, 281-290.
20. Jakeman, K. J., Smith, H., and Sweet, C. S. (1989). Mechanism of immunity to influenza: Maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins. Gen. Virol. 70, 1523-1530.
21. Junghans, R. P., and Anderson, C. L. (1996). The protection receptor for igg catabolism is the b2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93, 5512-5516.
22. Kaminski, M. S., Kitamura, K., Maloney, D. G., Campbell, M. J., and Levy, R. (1986). Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J. Immunol. 136, 1123-1130.
23. Kavaler, J., Caton, A. J., Staudt, L. M., Schwartz, D., and Gerhard, W. (1990). A set of closely related antibodies dominates the primary antibody response to the antigenic site Cb of the A/PR/8/34 influenza virus haemagglutinin. J. Immunol. 145, 2312-2321.
24. Klenk, H-D., and Rott, R. (1988). The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34, 247-281.
25. Kummer, U., Thierfelder, S., and Mysliwietz, J. (1990). Antigen density on target cells determines the immunosuppresive potential of rat IgG2b monoclonal antibodies. Eur. J. Immunol. 20, 107-112.
26. Lefrancois, L. (1984). Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: Distinct mechanisms of action in vivo. J. Virol. 51, 208-214.
27. Lepushkin, V. A., Katz, J. M., Black, R. A., Gamble, W. C., Rota, P. A., and Cox, N. J. (1995). Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. VacCine 13, 1399-1402.
28. Liang, S., Mozdfzanowska, K., Palladino, G., and Gerhard, W. (1994). Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152, 1653-1661.
29. Lukacher, A. E., Braciale, V. L., and Braciale, T. J. (1983). In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160, 814-826.
30. Mozdzanowska, K., Furchner, M., Washko, G., Mozdzanowski, J., and Gerhard, W. (1997). A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71, 4347-4355.
31. Murphy, B. R., Kasel, J. A., and Chanock, R. M. (1972). Association of serum anti-neuraminidase antibody with resistance to influenza in man. New Engl. J. Med. 286, 1329-1332.
32. Neuberger, M. S., and Rajewsky, K. (1981). Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11, 1012-1016.
33. Novak, M., Moldoveanu, Z., Schafer, D. P., Mestecky, J., and Compans, R. W. (1993). Murine model for evaluation of protective immunity to influenza virus. Vaccine 11, 55-60.
34. Palladino, G., Mozdzanowska, K., Washko, G., and Gerhard, W. (1995). Virus-neutralizing antibodies of immunoglobulin G (IgG) but not IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69, 2075-2081.
35. Pincus, S. H., Cole, R., Ireland, R., McAtee, F., Fujisawa, R., and Portis, J. (1995). Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus. J. Virol. 69, 7152-7158.
36. Ravetch, J. V., and Kinet, J. P. (1991). Fc receptors. Annu. Rev. Immunol. 9, 457-492.
37. Scherle, P. A., Palladino, G., and Gerhard, W. (1992). Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148, 212-217.
38. Schlesinger, J. J., Brandriss, M. W., and Walsh, E. E. (1985). Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135, 2805-2809.
39. Schlesinger, J. J., Foltzer, M., and Chapman, S. (1993). The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192, 132-141.
40. 2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope proteins fail to protect mice against lethal YF encephalitis. J. Gen. Virol. 76, 217-220.
41. Schmaljohn, A. L., Johnson, E. D., Dalrympl, J. M., and Cole, G. A. (1982). Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297, 70-72.
42. Schneider-Schaulies, S., Liebert, U. G., Segev, Y., Rager-Zisman, B., Wolfson, M., and Ter Meulen, V. (1992). Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J. Virol. 66, 5534-5541.
43. Schulman, J. L., and Kilbourne, E. D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bacteriol. 89, 170-174.
44. Schulman, J. L., Khakpour, M., and Kilbourne, E. D. (1968). Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J. Virol. 2, 778-786.
45. Seto, J.T., and Rott, R. (1966). Functional significance of sialidase during influenza virus multiplication. Virology 30, 731-737.
46. Simonson, L., Schonberger, L. B., Stroup, D. F., Arden, N. H., and Cox, N. J. (1996). The impact of influenza on mortality in the USA. Options for the Control of Influenza III (L. E. Brown, A. W. Hampson, and R. G. Webster, Eds.), pp. 26-33. Elsevier, Amsterdam.
47. Stanley, J., Cooper, S. J., and Griffin, D. E. (1986). Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J. Virol. 58, 107-115.
48. Taylor, G., Stott, E. J., Bew, M., Fernie, B. F., Cote, P. J., Collins, A. P., Hughe, M., and Jebbett, J. (1984). Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
49. + T cells is inefficient in the absence of B cells. J. Virol. 72, 882-885.
50. Treanor, J. J., Tierney, E. L., Zebede, S. L., Lamb, R. L., and Murphy, B. R. (1990). Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J. Virol. 64, 1375-1377.
51. Tyler, K. L., Mann, M. A., Fields, B. N., and Virgin, H. W. (1993). Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J. Virol. 67, 3446-3453.
52. Vieira, P., and Rajewsky, K. (1988). The half-lives of serum immunoglobulins in adult mice. Eur. J. Immunol. 18, 313-316.
53. Webster, R. G., Laver, W. G., and Kilbourne, E. D. (1968). Reaction of antibodies with surface antigens of influenza virus. J. Gen. Virol. 3, 315-326.
54. Webster, R. G., Reay, P. A., and Laver, W. G. (1988). Protection against lethal influenza with neuraminidase. Virology 164, 230-237.
55. -) variants obtained by mutagenesis of mouse mastocytoma P815. Immunogenetics 26, 178-187.
56. Yetter, R. A., Lehrer, S., Ramphal, R., and Small, P. A. (1980). Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity. Infect. Immunity 29, 654-662.
57. Yousaf, N., Howard, J. C., and Williams, B. D. (1993). Complement-dependent synergistic effects of rat monoclonal IgG antibodies in vivo. Eur. J. Immunol. 23, 369-375.
58. Yuan, R., Clynes, R., Oh, J., Ravetch, J. V., and Scharff, M. D. (1998). Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J. Exp. Med. 187, 641-648.
59. Zebedee, S. L., and Lamb, R. A. (1988). Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62, 2762-2772.